Eaton Vance Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.2M Sell
7,634
-266
-3% -$42.4K ﹤0.01% 1190
2022
Q2
$1.18M Sell
7,900
-540
-6% -$78.2K ﹤0.01% 1221
2022
Q1
$1.38M Buy
8,440
+7,967
+1,684% +$1.31M ﹤0.01% 1291
2021
Q4
$103K Sell
473
-5
-1% -$1.05K ﹤0.01% 1822
2021
Q3
$3K Buy
478
+3
+0.6% +$547 ﹤0.01% 1881
2021
Q2
$84K Buy
475
+333
+235% +$57.5K ﹤0.01% 1967
2021
Q1
$23K Buy
+142
New +$21.7K ﹤0.01% 2022

Other funds holding MEDP

Eaton Vance Management's MEDP Position: Q3 2022 in Review

Eaton Vance Management reduced its Medpace (MEDP) stake by 3.4% in Q3 2022, selling an estimated $42.4K and leaving 7,634 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Eaton Vance Management first reported a position in MEDP in Q1 2021 and has held it in 7 quarters since. The position peaked at $1.38M in Q1 2022. 357 funds tracked by Wall St. Rank hold MEDP as of Q3 2022.

  • Eaton Vance Management held 7,634 shares of Medpace worth $1.2M as of Q3 2022.
  • Eaton Vance Management sold 266 Medpace shares in Q3 2022, an estimated $42.4K.
  • Medpace made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1190 holding.
  • Eaton Vance Management first reported a position in Medpace in Q1 2021 and has held it in 7 quarters since.
  • Eaton Vance Management's Medpace position peaked at $1.38M in Q1 2022.
  • 357 funds tracked by Wall St. Rank held Medpace as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.